Looking for a Growth Stock? 3 Reasons Why PTC Inc. (PTC) is a Solid Choice
PTC Inc. (PTC) is well positioned to outperform the market, as it exhibits above-average growth in financials.
Can PTC Inc. (PTC) Run Higher on Rising Earnings Estimates?
PTC Inc. (PTC) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
Here's Why PTC Inc. (PTC) is a Strong Growth Stock
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
PTC Inc. (PTC) Q3 2025 Earnings Call Transcript
PTC Inc. (NASDAQ:PTC ) Q3 2025 Earnings Conference Call July 30, 2025 5:00 PM ET Company Participants Kristian P. Talvitie - Executive VP & CFO Matthew Shimao - Senior Vice President of Investor Relations Neil Barua - President, CEO & Director Robert Dahdah - Executive VP & Chief Revenue Officer Conference Call Participants Adam Charles Borg - Stifel, Nicolaus & Company, Incorporated, Research Division Andrew Burris Obin - BofA Securities, Research Division Blair Harold Abernethy - Rosenblatt Securities Inc., Research Division Hoi-Fung Wong - Oppenheimer & Co. Inc., Research Division Jason Vincent Celino - KeyBanc Capital Markets Inc., Research Division Jay Vleeschhouwer - Griffin Securities, Inc., Research Division Joseph D.
PTC Inc. (PTC) Reports Q3 Earnings: What Key Metrics Have to Say
The headline numbers for PTC Inc. (PTC) give insight into how the company performed in the quarter ended June 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
PTC Inc. (PTC) Beats Q3 Earnings and Revenue Estimates
PTC Inc. (PTC) came out with quarterly earnings of $1.64 per share, beating the Zacks Consensus Estimate of $1.22 per share. This compares to earnings of $0.98 per share a year ago.
Ahead of PTC Inc. (PTC) Q3 Earnings: Get Ready With Wall Street Estimates for Key Metrics
Beyond analysts' top-and-bottom-line estimates for PTC Inc. (PTC), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended June 2025.
US FDA approves PTC Therapeutics' metabolic disorder drug
The U.S. Food and Drug Administration has approved PTC Therapeutics' oral drug to treat a rare inherited metabolic disorder that prevents the body from properly breaking down certain amino acids, the company said on Monday.
PTC to Announce Q3 Earnings: Here's What You Should Know
PTC expects Q3 revenues of up to $600M and EPS as high as $1.30, driven by AI-powered PLM and CAD momentum.
PTC Inc. (PTC) Is Up 3.15% in One Week: What You Should Know
Does PTC Inc. (PTC) have what it takes to be a top stock pick for momentum investors? Let's find out.
PTC Inc. (PTC) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
PTC Inc. (PTC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Why PTC Inc. (PTC) is a Top Growth Stock for the Long-Term
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
